Windy Dean‐Colomb

930 total citations
26 papers, 625 citations indexed

About

Windy Dean‐Colomb is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Windy Dean‐Colomb has authored 26 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Windy Dean‐Colomb's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Windy Dean‐Colomb is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Windy Dean‐Colomb collaborates with scholars based in United States, Bangladesh and China. Windy Dean‐Colomb's co-authors include Francisco J. Esteva, Clayton Yates, Ming Tan, Honghe Wang, Balasubramanyam Karanam, Melissa B. Davis, William E. Grizzle, Ritu Arora, David Schmitt and Laurie B. Owen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Windy Dean‐Colomb

24 papers receiving 616 citations

Peers

Windy Dean‐Colomb

ONCOL

PRM

RNMI

Guoxian Long China

Henri Wichmann Germany

Stella Logotheti Germany

Dimitra Tsavachidou United States

Christine Wittig Germany

Toshi Yoneda Japan

Yi Ming Mu China

Orsolya Csuka Hungary

Wei Jing China

Siker Kimbung Sweden

Guoxian Long China

Windy Dean‐Colomb

289 ×0.8

217 ×0.9

291 ×1.2

ONCOL

108 ×1.3

PRM

45 ×0.7

RNMI

Citations per year, relative to Windy Dean‐Colomb Windy Dean‐Colomb (= 1×) peers Guoxian Long

Countries citing papers authored by Windy Dean‐Colomb

Since Specialization

Citations

This map shows the geographic impact of Windy Dean‐Colomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Windy Dean‐Colomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Windy Dean‐Colomb more than expected).

Fields of papers citing papers by Windy Dean‐Colomb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Windy Dean‐Colomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Windy Dean‐Colomb. The network helps show where Windy Dean‐Colomb may publish in the future.

Co-authorship network of co-authors of Windy Dean‐Colomb

This figure shows the co-authorship network connecting the top 25 collaborators of Windy Dean‐Colomb. A scholar is included among the top collaborators of Windy Dean‐Colomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Windy Dean‐Colomb. Windy Dean‐Colomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schoenberger, Yu‐Mei, Windy Dean‐Colomb, Roland Matthews, et al.. (2024). Addressing Barriers and Facilitators to African Americans’ and Hispanics’ Participation in Clinical and Genomic Research Through a Bioethical Sensitive Video. Journal of Cancer Education. 39(4). 464–470.

Jenkins, Brittany D., Sandeep K. Singhal, Kevin Gardner, et al.. (2023). Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling. Cancers. 15(8). 2282–2282. 3 indexed citations

Angajala, Anusha, Aliyu Muhammad, Honghe Wang, et al.. (2022). MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. Scientific Reports. 12(1). 22178–22178. 4 indexed citations

Mukherjee, Ujjal Kumar, Panagiotis Mistriotis, Windy Dean‐Colomb, et al.. (2022). Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers. 14(23). 6009–6009. 9 indexed citations

Dean‐Colomb, Windy, Rachel Martini, Akanksha Verma, et al.. (2020). Ancestry-specific gene expression profiles in TNBC tumors.. Journal of Clinical Oncology. 38(15_suppl). 1547–1547. 1 indexed citations

Angajala, Anusha, Melissa B. Davis, Shweta Tripathi, et al.. (2018). Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Translational Oncology. 12(3). 493–501. 23 indexed citations

Angajala, Anusha, et al.. (2018). Abstract A04: Identification of differentially expressed micro-RNAs in African American women with quadruple-negative breast cancer. Cancer Epidemiology Biomarkers & Prevention. 27(7_Supplement). A04–A04. 3 indexed citations

Angajala, Anusha, et al.. (2018). Abstract 4769: Identification of differentially expressed microRNAs in African American women with quadruple-negative breast cancer. Cancer Research. 78(13_Supplement). 4769–4769. 2 indexed citations

Jones, Jacqueline, Angana Mukherjee, Balasubramanyam Karanam, et al.. (2016). African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Letters. 380(2). 513–522. 16 indexed citations

10.

Wang, Honghe, Wei Liu, Juliet M. Daniel, et al.. (2015). Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. Oncotarget. 7(5). 5677–5689. 40 indexed citations

11.

Arora, Ritu, David Schmitt, Balasubramanyam Karanam, et al.. (2015). Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 6(2). 662–678. 47 indexed citations

12.

Jones, Jacqueline, Honghe Wang, Balasubramanyam Karanam, et al.. (2014). Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clinical & Experimental Metastasis. 31(5). 497–510. 33 indexed citations

13.

Arora, Ritu, Bernard D. Gary, Steven McClellan, et al.. (2013). Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.. Cancer Research. 73(8_Supplement). 5571–5571. 1 indexed citations

14.

Dean‐Colomb, Windy, Kenneth R. Hess, Elliana Young, et al.. (2012). Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer. Breast Cancer Research and Treatment. 137(2). 631–636. 24 indexed citations

15.

Gao, Lin, Qinghua Cui, Bernard D. Gary, et al.. (2012). Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs. Oncogene. 31(48). 4979–4986. 58 indexed citations

16.

Ding, Yan, Zixing Liu, Shruti Desai, et al.. (2012). Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nature Communications. 3(1). 1271–1271. 92 indexed citations

17.

Dean‐Colomb, Windy & Sharon H. Giordano. (2010). Cancer Treatment Adherence Among Low-Income Women With Breast or Gynecologic Cancer: A Randomized Controlled Trial of Patient Navigation. Breast Diseases A Year Book Quarterly. 21(1). 30–32. 6 indexed citations

18.

Dean‐Colomb, Windy, et al.. (2009). Off-label drug use in women with breast cancer. Journal of Clinical Oncology. 27(15_suppl). 1016–1016. 6 indexed citations

19.

Dean‐Colomb, Windy & Francisco J. Esteva. (2008). Her2-positive breast cancer: Herceptin and beyond. European Journal of Cancer. 44(18). 2806–2812. 154 indexed citations

20.

Dean‐Colomb, Windy & Francisco J. Esteva. (2008). Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer. Seminars in Oncology. 35(2 Suppl 2). S31–S38. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact